Angiogenesis and its therapeutic implication. 5. Bone marrow angiogenesis and anti-angiogenic therapy in multiple myeloma

研究成果: Article査読

抄録

In summary, increased bone marrow MVD as well as plasma concentrations of angiogenic growth factors are correlated with disease activity in MM. These results suggest that bone marrow angiogenesis may be an important factor for disease progression and can also be a therapeutic target. Thalidomide, known as an inhibitor of angiogenesis, was effective for the treatment of refractory MM. However, special caution must be paid to it's adverse effects.

本文言語English
ページ(範囲)303-305
ページ数3
ジャーナルInternal Medicine
42
3
DOI
出版ステータスPublished - 2003 3 1

ASJC Scopus subject areas

  • 内科学

フィンガープリント

「Angiogenesis and its therapeutic implication. 5. Bone marrow angiogenesis and anti-angiogenic therapy in multiple myeloma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル